USPTO serial 79274572
ULTRARUN
Reviewed by CopyMark Law Group
Reg. 6121360Status 708Renewal
- Filing date
- Status date
- Registration date
- Aug 11, 2020
- Examiner
- BETTS, MARCYA N
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ULTRARUN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel M. Gurfinkel
Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological diagnostic preparations used in science; non-medical reagents, enzymes and chemicals, namely, buffer solutions, used in analytical chemistry, for scientific and medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, and for the analysis of reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, and for the analysis of reagents, enzymes and buffer solutions for nucleic acid amplification and cloning | ACTIVE | — |
| 005 | [ Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 17, 2026 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 8, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 16, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Aug 11, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 26, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 4, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 4, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 11, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 11, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 26, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 21, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 21, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 27, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 23, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |